BioAcyl Corp

WIKINDX Resources  

Ahmed, S. M. U., Luo, L., Namani, A., & others. (2017). Nrf2 signaling pathway: Pivotal roles in inflammation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1863(2), 585–597. 
Added by: Dr. Enrique Feoli (22/05/2021, 08:32)   Last edited by: Dr. Enrique Feoli (22/05/2021, 08:36)
Resource type: Journal Article
DOI: 10.1016/j.bbadis.2016.11.005
ID no. (ISBN etc.): 0925-4439
BibTeX citation key: Ahmed2017
View all bibliographic details
Categories: BioAcyl Corp
Subcategories: Nrf2 signaling
Creators: Ahmed, Luo, Namani, others
Collection: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Views: 6/340
Abstract
{Inflammation is the most common feature of many chronic diseases and complications, while playing critical roles in carcinogenesis. Several studies have demonstrated that Nrf2 contributes to the anti-inflammatory process by orchestrating the recruitment of inflammatory cells and regulating gene expression through the antioxidant response element (ARE). The Keap1 (Kelch-like ECH-associated protein)/Nrf2 (NF-E2 p45-related factor 2)/ARE signaling pathway mainly regulates anti-inflammatory gene expression and inhibits the progression of inflammation. Therefore, the identification of new Nrf2-dependent anti-inflammatory phytochemicals has become a key point in drug discovery. In this review, we discuss the members of the Keap1/Nrf2/ARE signal pathway and its downstream genes, the effects of this pathway on animal models of inflammatory diseases, and crosstalk with the NF-{$kappa$}B pathway. In addition we also discuss about the regulation of NLRP3 inflammasome by Nrf2. Besides this, we summarize the current scenario of the development of anti-inflammatory phytochemicals and others that mediate the Nrf2/ARE signaling pathway.}
  
Notes
Phytochemicals/drugsChemical compound/groupUses in disease modelClinical trialReferences
EGCG Flavonoids Lupus nephritis, Aβ induced neuro inflammation Phase II [81], [99], [137], [138]
Astaxanthin Carotenoids Chronic inflammatory diseases, cardiovascular diseases Phase I [3], [139]
Curcumin Curcuminoids Spinal cord injury, mastitis Phase II [132], [140], [141]
Sulfoaphane Organosulfides UV dermatitis, AD nasal inflammation, eradicate H. pylori infection in DM-2 patient Phase I & II [142], [143], [144], [145]
Resveratrol Stylbenes CKD, UC Phase II [146], [147]
DMF, CDDO-Me/RTA402 Triterpenoids HD, MS, PH, HIV, CKD, DM-2, Psoriasis, Hepatopathy Phase II & III [148], [149], [150]
Tecfidera Triterpenoids MS Phase III [151], [152]
RT408 Triterpenoids Radiation induced dermatitis Phase II [153]
Quercetin Flavonoids Pulmonary infection Phase II [154]
Catechin Flavan-3-Ols Periodontosis, NAFLD Phase II [155], [156]
Silymarin Lignans NAFLD, UC, chronic Hepatitis Phase II [157], [158], [159]
Soy genistein Isoflavones Bronchial asthma Phase II [160]
Cernilton Non specific Chronic prostatitis Phase III [161], [162]
Eviprostat Non specific Chronic prostatitis Phase III [162]
VEDA 1209 Non specific UC Preclinical [152]
Artesunate ART Septic lung injury Preclinical [127]
Isovitexin Glycosylflavonoids Acute lung injury (LPS induced) Preclinical [128]
Fimasartan ARB Unilateral ureteral obstruction Preclinical [129]
Sappanone Homioisoflavanones LPS induced Inflammation Preclinical [130]
Bixin Carotenoids Ventilation induced lung injury Preclinical [131]
Eriodictyol Flavonoids Kidney injury(cisplatin induced), septic lung injury Preclinical [135], [136]
Anthocyanynin Flavonoids Atheroscerosis Preclinical [124]

  
WIKINDX 6.12.1 | Total resources: 1701 | Username: -- | Bibliography: WIKINDX Master Bibliography | Style: American Psychological Association (APA) | Time Zone: America/Costa_Rica (-06:00)